New HIV vaccine trial aims to train immune system to beat the virus

NCT ID NCT06006546

Ongoing ⭐️ VACCINE ⭐️ Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated May 25, 2026 · Updated 30 times

Summary

This early-stage study tests an experimental HIV vaccine in 35 people living with HIV. The goal is to see if the vaccine can safely train the immune system to produce special antibodies that might help control the virus. Participants will temporarily pause their regular HIV medications to see if the vaccine works.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC HIV INFECTION are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Locations

Atlanta- Ponce

Atlanta, Georgia, 30303, United States
BIDMC

Boston, Massachusetts, 02215, United States
Birmingham

Birmingham, Alabama, 35294-2170, United States
Columbia P&S CRS Site#30329

New York, New York, 10032, United States
Fred Hutchinson Cancer Research Center

Seattle, Washington, 98109, United States
Seattle Vaccine and Prevention CRS (Site # 30331)

Seattle, Washington, 98104, United States
The Hope Clinic of the Emory Vaccine Center CRS (Site #31440)

Decatur, Georgia, 30030, United States
University of Pittsburg

Pittsburgh, Pennsylvania, 15213, United States

Conditions

Explore the condition pages connected to this study.

CHRONIC HIV INFECTION